FAScinate Therapeutics, Inc. Cleared for Phase 2 Clinical Trials of Company’s Parkinson’s Disease Treatment with Approval from U.S. Food and Drug Administration Read Now >
Tuesday, November 23, 2021 / BioSpace
Tuesday, November 23, 2021 / BioSpace
Wednesday, November 17, 2021 / PRWeb
Wednesday, November 17, 2021 / Parkinson's News Today
Friday, November 5, 2021 / FAScinate Therapeutics
Monday, January 7, 2019 / Senior Health News